HCV - AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...

AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...
PharmaLive.com (press release), PA - Jan 13, 2006... this approach can be, but it is also encouraging for our work in treating additional viral diseases, such as chronic hepatitis C infection, which currently ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

BioCryst Reports Fourth Quarter and Year-End 2005 Financial ...
International News Service, Australia - Feb 8, 2006... Early in 2005 we isolated a lead compound in our polymerase inhibitor program, BCX-4678 for the treatment of patients with hepatitis C infection. ...

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...